Welcome to our dedicated page for Datametrex AI news (Ticker: DTMXF), a resource for investors and traders seeking the latest updates and insights on Datametrex AI stock.
Datametrex AI Limited reports developments across technology solutions, artificial intelligence and healthcare, with recurring updates tied to data centre operations, private cloud infrastructure and managed services for enterprise customers. Company announcements describe purchase orders for hyperconverged infrastructure software, technical support and AI-enabled resource optimization, including work delivered through Datametrex Korea.
News also covers the company's use of AI-assisted functionality in electronic medical records and the intellectual property activities of wholly owned subsidiary Paymetrex Payment Solutions Inc. Paymetrex updates include patent licensing and monetization initiatives involving secure transaction processing, payment authorization workflows, mobile-based acceptance architectures and potential relevance to SoftPOS and next-generation secure payment environments.
Datametrex AI (DTMXF) plans to wind down its health care operations to focus on its core AI, data centre technology, and patent licensing businesses.
The company intends to gradually reduce and ultimately cease its health care activities, including multi-disciplinary medical clinics in Edmonton, Calgary, and Vancouver, which currently provide primary and emergency care. Management plans a measured, orderly transition based on operational, financial, contractual, and regulatory factors, while seeking to maximize value from health care assets. The company expects this shift to simplify its corporate structure, reduce operating and regulatory compliance requirements, and support long-term objectives in AI, data centre, and patent licensing, where patent licensing initiatives remain active.
Datametrex AI (OTC:DTMXF) will change its name to Quanta AI, with trading on the TSX Venture expected to begin under new ticker QNTA on or about September 14, 2026. A new CUSIP, 74768Q109, will replace the previous identifier, with no action required from existing shareholders.
The company announced leadership changes: Michael Kron has been appointed Chief Executive Officer and Chairman of the Board, succeeding Paul Haber, who resigned on August 28, 2026. Bruce Lee has been appointed Chief Financial Officer following the resignation of Don Shim on August 31, 2026.
Datametrex (OTC:DTMXF) reported the voting results from its Annual and Special Meeting of Shareholders held on August 28, 2026. A total of 25,601,048 shares, representing 16.778% of issued and outstanding shares, were represented in person or by proxy, and all resolutions were approved.
Shareholders elected four directors (Paul Haber, Michael Kron, Sol Avisar and Greg Waite) with 25,507,167 votes, or 99.634% of shares represented. The omnibus incentive plan was re-approved with 24,887,592 votes (98.276%). Auditors were appointed with 25,431,334 votes (99.338%), and a corporate name change was approved with 25,432,531 votes (99.343%). According to Datametrex, full resolution details are available in the July 8, 2026 Management Information Circular on SEDAR+ and the company website.
Datametrex (OTC PINK:DTMXF) announced it will adopt a semi-annual financial reporting schedule under Coordinated Blanket Order 51-933 for certain venture issuers. The company’s fiscal year ends on March 31 and it will no longer file interim financial statements and MD&A for the three-month periods ending June 30 and December 31.
Datametrex will continue to report results for the six-month period ending September 30 and for its full fiscal year ending March 31, in line with applicable securities laws. According to Datametrex, this change is expected to reduce the administrative burden of quarterly reporting and allow management to allocate more resources to business operations and strategic priorities, while maintaining its continuous disclosure obligations.
Datametrex AI (OTC:DTMXF) announced that subsidiary QuantIP Licensing completed AI-based evaluations of two U.S. information-analytics patents (Nos. 9,275,015 and 9,665,561, priority 2012).
The patents, expiring around 2032, were assessed by Pelent AI and VisiLeap. Based on these reviews, QuantIP is preparing a structured patent licensing program, though no licensees, negotiations, or infringement analyses exist yet and revenue is not assured.
Datametrex (OTC:DTMXF) announced that its wholly owned subsidiary Paymetrex Payment Solutions has been renamed QuantIP Licensing Corp.
The new brand reflects a strategic focus on licensing and monetizing payment-related intellectual property spanning payments, cybersecurity, artificial intelligence, and emerging quantum encryption. According to Datametrex, operations, ownership, and structure remain unchanged, and quantum encryption activities are at an early stage with no assurance of commercial outcomes.
Datametrex (OTC:DTMXF) announced that in the first half of 2026 it secured multiple enterprise software licensing, implementation, operations, maintenance, and automation service contracts worth about CAD $650,000. The Company expects an approximate 75% net profit margin on these contracts, which focus on workflow and process automation.
Datametrex (OTC:DTMXF) announced multiple enterprise infrastructure contracts totaling about CAD $1.8 million for Nutanix-based data centre modernization. The company expects roughly 10% net profit from these projects, which focus on upgrading server infrastructure and delivering Nutanix hyperconverged infrastructure to enhance performance, scalability, and operational efficiency.
Datametrex AI (OTC:DTMXF) announced that Hilco Global has completed its initial qualifying due diligence review of the patent portfolio owned by subsidiary Paymetrex Payment Solutions. The portfolio passed Hilco’s internal qualification process and is slated to advance into a structured licensing initiative focused on SoftPOS and mobile payment technologies.
The parties anticipate a broader licensing program could begin in about two months, though Datametrex cautions the initiative is exploratory and there is no assurance of any licensing, royalty, or other commercial agreements.
Datametrex AI (OTC:DTMXF) announced that subsidiary Imagine Health has gained teaching facility status at its Calgary Capitol Hill clinic through a partnership with a University of Calgary faculty member, Dr. Michael Tam.
The move supports physician recruitment, rheumatology access via Dr. Richard Akintayo, and added walk-in and family care in Edmonton from June 1, 2026.